Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial update evaluating whether adding donor stem cell transplantation to combination chemotherapy improves outcomes in adu…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 trial evaluating genetically modified haploidentical natural killer cell infusions for B-lineage acute lymphoblastic leukemia has co…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma [Phase 1]
Phase 1 compassionate-use update of Erwinase (L-asparaginase from Erwinia chrysanthemi) for pediatric acute lymphoblastic leukemia and non-H…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy [Phase 3]
Phase 3 trial evaluating consolidation therapy with 6-mercaptopurine in children with acute lymphoblastic leukemia within the ALL2008 protoc…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission
This is a completed clinical trial assessing metabolic syndrome and long-term health effects in young patients with acute lymphoblastic leuk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating MS-275 (entinostat) in combination with GM-CSF in adults with myelodysplastic syndromes and/or relapsed or refracto…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia [Phase 2]
A Pfizer-sponsored Phase 2 trial evaluating inotuzumab ozogamicin in acute lymphoblastic leukemia has completed and posted results in April …
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
This clinical trial update reports results from a completed study evaluating saline-washed platelet and red cell transfusions in adults with…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia
The trial update reports instances of kidney dysfunction in children and young adults treated with methotrexate for acute lymphoblastic leuk…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs [Phase 2]
A Phase 2 safety and tolerability trial evaluating CDX-301 with or without plerixafor for stem cell mobilization in matched related donor/re…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [Phase 2]
Phase 2 clinical trial evaluating nonmyeloablative allogeneic stem cell transplantation for various hematologic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [NA]
A terminated clinical trial evaluated mobilizing donor peripheral blood stem cells with plerixafor and filgrastim before donor transplant in…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Treatment of Older Adults With Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial results for treating older adults with acute lymphoblastic leukemia have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies [Phase 1]
Phase 1 clinical trial update describing safety assessments for two infusion schedules of SNS-595 in patients with hematologic malignancies.…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports completion of a study evaluating an investigational biological therapy in adults with advanced mye…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment [NA]
Clinical trial results posted on using hyperbaric oxygen therapy to improve umbilical cord blood stem cell homing and engraftment in patient…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Exergaming Intervention in ALL Patients [NA]
This document provides an update on a completed clinical trial evaluating an exergaming intervention in patients with Acute Lymphoblastic Le…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hema…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy [Phase 1]
Phase 1 trial evaluating CART19 therapy for B-cell hematologic malignancies including various lymphomas and leukemias that are refractory or…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma [Phase 2]
Phase 2 pediatric trial for relapsed or refractory B-cell acute lymphoblastic leukemia or lymphoblastic lymphoma sponsored by MedImmune; the…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) [Phase 2]
Phase 2 dose confirmation and pharmacokinetic study of pegcrisantaspase given IV in children and young adults with acute lymphoblastic leuke…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant [Phase 2]
Phase 2 trial of T-cell replete haploidentical donor hematopoietic stem cell transplantation with natural killer (NK) cell support in hemato…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant [Phase 1, Phase 2]
This update covers a phase 1/2 clinical trial evaluating CD19 CAR T cells for B-cell malignancies in patients after allogeneic transplantati…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [Phase 1, Phase 2]
Phase 1 and Phase 2 results are reported for allogeneic cytokine-induced killer (CIK) cell immunotherapy given to patients who relapsed afte…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission [Phase 3]
Phase 3 trial evaluating tacrolimus and methotrexate with or without sirolimus to prevent graft-versus-host disease in young patients underg…